Fluctuation Analyses of Asthma Patients With Biologics Use
NCT06024707 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 48
Last updated 2023-11-01
Summary
The goal of this observational study is to compare the fluctuation patterns of biomarkers (Spirometry, FeNO, IOS) of responders and non-responders in asthma patients who will start treatment with a biologic. The main question it aims to answer is: Can fluctuation patterns of parameters for spirometry, FeNO and IOS before and after starting treatment with biologics in patients with severe asthma be used to predict a successful intervention.
Participants will measure Spirometry, FeNO and IOS twice a day at home for 2 or 3 months starting one month before starting treatment with a biological.
Conditions
Interventions
- DRUG
-
Biological Drug
This intervention is part of regular treatment, subjects will be included if they get this treatment.
Sponsors & Collaborators
-
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
lead OTHER
Principal Investigators
-
Els Weersink, Dr. · Amsterdam UMC, location AMC
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-31
- Primary Completion
- 2024-09-30
- Completion
- 2024-09-30
More Related Trials
-
Asthma: Phenotyping Exacerbations 2
NCT04293445 ·Status: UNKNOWN
-
A 12-Week Study in Adult Subjects With Asthma
NCT01516086 ·Status: COMPLETED ·Phase: PHASE2
-
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
NCT06621056 ·Status: RECRUITING
-
This is a 6-month Observational Study. Patients Included Will be Those Referred With a Possible Diagnosis or an Established Diagnosis of Asthma. It Will Look at the Association of the Asthma Microbiome and Disease Characteristics, Severity and Treatment Response.
NCT06028204 ·Status: UNKNOWN
-
A Study To Estimate The Relative Bioavailability Of PF-00258210 Administered Alone Or In Combination With PF-00610355
NCT01043276 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
NCT06637371 ·Status: RECRUITING ·Phase: PHASE1
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
Asthma Biomarkers for Predicting Response to Therapy
NCT01973751 ·Status: UNKNOWN ·Phase: NA
-
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
NCT01589198 ·Status: COMPLETED
-
Asthma: Phenotyping EXacerbations
NCT04293588 ·Status: UNKNOWN
-
Does Asthma Phenotype Have Impact on Disease Control
NCT01978678 ·Status: COMPLETED
-
Phase II Study to Evaluate the Efficacy of AMG 317
NCT00436670 ·Status: COMPLETED ·Phase: PHASE2
-
Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients
NCT02126865 ·Status: COMPLETED ·Phase: PHASE1
-
12-Week Study in Adult Subjects With Asthma
NCT01516073 ·Status: COMPLETED ·Phase: PHASE2
-
Phenotyping Responses to Systemic Corticosteroids in the Management of Asthma Attacks
NCT05870215 ·Status: COMPLETED
-
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3
NCT01224964 ·Status: TERMINATED ·Phase: NA
-
Prospective Study of the Feedback From an Adherence Monitor on Asthma Control
NCT01529697 ·Status: COMPLETED ·Phase: NA
-
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients
NCT06605885 ·Status: ACTIVE_NOT_RECRUITING
-
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
NCT05136547 ·Status: COMPLETED
-
AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma
NCT01018550 ·Status: COMPLETED ·Phase: PHASE2
-
Maintenance at Initial Treatment With Sequential Anti-Inflammation Reliever Therapy
NCT06568445 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Retrospective Cohort Study on Asthma With Frequent Acute Attacks Phenotype
NCT06026462 ·Status: NOT_YET_RECRUITING
-
Phenotyping Disease Severity in Asthma
NCT05078021 ·Status: RECRUITING
-
Study to Evaluate the Impact of FeNO Assessments on Asthma Management Decisions in Subject 7 to 60 Years of Age
NCT01729247 ·Status: COMPLETED
-
Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma
NCT07189806 ·Status: RECRUITING